XML 78 R20.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value of Financial Instruments
6 Months Ended
Jun. 30, 2021
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments

Note 14:

Fair Value of Financial Instruments

The carrying amount of certain of the Company’s financial instruments, including cash and cash equivalents, net accounts receivable, accounts payable and other accrued liabilities approximate fair value due to their short-term nature.

The Company measures the value of its equity investments without readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment.  During the three and six months ended June 30, 2021 and 2020, there were no observable price changes in identical or similar investments, nor were there any indications of impairment.  As such, the value of the Company’s equity investments was not remeasured.

Assets and Liabilities Measured at Fair Value on a Recurring Basis

The Company evaluates its financial assets and liabilities subject to fair value measurements on a recurring basis to determine the appropriate level in which to classify them for each reporting period. This determination requires significant judgments. The following table summarizes the conclusions reached regarding fair value measurements as of June 30, 2021 and December 31, 2020 (in thousands):

 

 

Balance at June 30, 2021

 

 

Quoted Prices in Active Markets for Identical Assets

(Level 1)

 

 

Significant Other Observable Inputs

(Level 2)

 

 

Significant Unobservable Inputs

(Level 3)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity securities

$

5,378

 

 

$

5,378

 

 

$

 

 

$

 

Total

$

5,378

 

 

$

5,378

 

 

$

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Warrant liability, related party (1)

$

3,588

 

 

$

 

 

$

 

 

$

3,588

 

Total

$

3,588

 

 

$

 

 

$

 

 

$

3,588

 

 

 

Balance at December 31, 2020

 

 

Quoted Prices in Active Markets for Identical Assets

(Level 1)

 

 

Significant Other Observable Inputs

(Level 2)

 

 

Significant Unobservable Inputs

(Level 3)

 

Warrant liability, related party (1)

$

2,871

 

 

$

 

 

$

 

 

$

2,871

 

Total

$

2,871

 

 

$

 

 

$

 

 

$

2,871

 

 

(1)

Fair value determined using the Black-Scholes option pricing model.  Expected volatility is based on historical volatility of its own stock. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the valuation.

 

 

Changes in Level 3 instruments for the six months ended June 30,

 

 

Balance at January 1

 

 

Net Change in

fair value included in earnings

 

 

Purchases /

Issuance

 

 

Sales /

Repurchases

 

 

Balance at June 30,

 

2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Warrant liability, related party

$

2,871

 

 

$

717

 

 

$

 

 

$

 

 

$

3,588

 

Total

$

2,871

 

 

$

717

 

 

$

 

 

$

 

 

$

3,588

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Warrant liability, related party

$

2,601

 

 

$

928

 

 

$

 

 

$

 

 

$

3,529

 

Total

$

2,601

 

 

$

928

 

 

$

 

 

$

 

 

$

3,529

 

 

During the three and six months ended June 30, 2021, Reneo completed its initial public offering.  As a result, the fair value of the Company’s investment in Reneo’s common stock now has a readily determinable market value and is no longer eligible for the

practical expedient for investments without readily determinable fair market values.  As such, the Company’s investment in Reneo is adjusted each reporting period to its fair value based on its most recent closing price, which is considered a Level 1 fair value measurement under the fair value hierarchy.    

The change in fair value of the Letter Agreement Warrants are recognized as a component of other (expense) income – related party in the Condensed Consolidated Statements of Operations.  Significant inputs utilized in the valuation of the Letter Agreement Warrants as of June 30, 2021 and December 31, 2020 were:

 

 

 

June 30, 2021

 

 

December 31, 2020

 

 

Range

Weighted Average

 

 

Range

Weighted Average

 

Expected volatility

125.32% - 151.38%

135.36%

 

 

120.53% - 142.07%

128.16%

 

Risk-free interest rate

0.55% - 0.95%

0.79%

 

 

0.26% - 0.50%

0.39%

 

 

The weighted average expected volatility and risk-free interest rate was based on the relative fair values of the warrants.

Changes in the unobservable inputs noted above would impact the amount of the liability for the Letter Agreement Warrants.  Increases (decreases) in the estimates of the Company’s annual volatility would increase (decrease) the liability and an increase (decrease) in the annual risk-free rate would increase (decrease) the liability.